HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of antipain-sensitive protease activity in the interferon-beta-induced UV-refractoriness of Cockayne syndrome fibroblasts.

Abstract
Fibroblast cells obtained from two siblings and a female patient with Cockayne syndrome (CS), when pretreated with human interferon (HuIFN)-beta prior to irradiation with UV light (254 nm wavelength), exhibited transiently induced fibrinolytic protease activity immediately after the irradiation in association with increased refractoriness to UV cell-killing. A protease inhibitor, antipain, inhibited the induction of protease activity in lysates of the CS fibroblasts from these 3 cases after the combination of HuIFN-beta pretreatment and UV irradiation, whereas elastatinal and 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) inhibited the activity less than antipain did. Antipain also suppressed the increase in UV-refractoriness of HuIFN-beta-pretreated CS fibroblasts, as revealed by culturing cells for 24 h in medium containing the inhibitor immediately after UV exposure and thereafter evaluating the ability of colony formation by the cells. Thus, an antipain-sensitive protease may be involved in the UV-refractoriness induced by HuIFN-beta in CS fibroblast strains.
AuthorsK Sugita, N Suzuki, H Niimi
JournalMutation research (Mutat Res) Vol. 357 Issue 1-2 Pg. 177-81 (Oct 25 1996) ISSN: 0027-5107 [Print] Netherlands
PMID8876692 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protease Inhibitors
  • Antipain
  • Interferon-beta
  • Endopeptidases
Topics
  • Antipain (pharmacology)
  • Cell Survival (radiation effects)
  • Cockayne Syndrome (genetics)
  • Endopeptidases (metabolism)
  • Female
  • Humans
  • Interferon-beta (physiology)
  • Male
  • Pedigree
  • Protease Inhibitors (pharmacology)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: